Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukins. Clinical pharmacokinetics and practical implications.

V Bocci1

  • 1Institute of General Physiology and Nutritional Sciences, Faculty of Pharmacy, University of Siena, Italy.

Clinical Pharmacokinetics
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Dark-Matter-Nucleon Interactions via Migdal Effect with DarkSide-50.

Physical review letters·2023
Same author

Search for Dark Matter Particle Interactions with Electron Final States with DarkSide-50.

Physical review letters·2023
Same author

Constraints on the K_{S}^{0}→μ^{+}μ^{-} Branching Fraction.

Physical review letters·2020
Same author

Observation of Enhanced Double Parton Scattering in Proton-Lead Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2020
Same author

Feasibility study on the use of CMOS sensors as detectors in radioguided surgery with β<sup>-</sup>- emitters.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2020
Same author

Measurement of CP-Averaged Observables in the B^{0}→K^{*0}μ^{+}μ^{-} Decay.

Physical review letters·2020

Cytokines like interleukins and tumour necrosis factor (TNF) can cause toxicity when administered therapeutically due to nonphysiological plasma concentrations. Research is exploring new formulations and routes to improve their therapeutic index for better patient outcomes.

Area of Science:

  • Immunology and Pharmacology
  • Biochemistry of Cytokines

Background:

  • Interleukins and TNF are proteins with pleiotropic effects on target cells.
  • Physiologically, they are present in low, localized amounts with paracrine activity.
  • Therapeutic administration can lead to nonphysiological plasma concentrations and toxicity.

Purpose of the Study:

  • To evaluate the pharmacokinetics of specific interleukins (IL-1, IL-2, IL-3, IL-6) and TNF.
  • To understand the rapid clearance mechanisms of these cytokines from circulation.
  • To identify strategies for improving the therapeutic index of cytokine-based therapies.

Main Methods:

  • Pharmacokinetic evaluation of intravenous administration of IL-1, IL-2, IL-3, IL-6, and TNF.
  • Analysis of plasma disappearance rates, including distribution and elimination half-lives.

Related Experiment Videos

  • Assessment of catabolic pathways like renal filtration and liver uptake.

    • Main Results:

    • Rapid plasma disappearance of administered interleukins and TNF.
    • Distribution half-lives measured in minutes; elimination half-lives in hours.
    • Efficient clearance via renal filtration and liver uptake, indicating a natural protective mechanism.

    Conclusions:

    • Cytokines like interleukins and TNF are cleared rapidly from circulation.
    • Their potent immunomodulatory effects necessitate strategies to enhance therapeutic index.
    • Development of novel formulations and administration routes is crucial for safer and more effective cytokine therapy.